Skip to main content
i-SENS, Inc. logo

i-SENS, Inc. — Investor Relations & Filings

Ticker · 099190 ISIN · KR7099190001 KO Manufacturing
Open in API
Filings indexed 279 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 099190

About i-SENS, Inc.

https://i-sens.com/

i-SENS, Inc. is a global in vitro diagnostics company founded in 2000 that specializes in the research, development, and production of biosensors and electrochemical technology. The company's core business focuses on diabetes management, offering a comprehensive portfolio of products including blood glucose monitoring systems (BGMS) and continuous glucose monitoring systems (CGMS) under its CareSens brand. In addition to its diabetes care solutions, i-SENS develops and manufactures point-of-care testing (POCT) devices, such as electrolyte and gas analyzers, and provides veterinary diagnostic solutions. With an annual production capacity of over two billion blood glucose test strips, the company distributes its products to healthcare markets in more than 110 countries.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 94% confidence The document is the full text of a Korean quarterly report (분기보고서) for the 27th fiscal term covering Q1 (2026-01-01 to 2026-03-31). It contains extensive financial statements, business descriptions, production data, notes, and other detailed content typical of an interim/quarterly filing. It is not a brief announcement, transcript, or proxy solicitation, nor is it merely an announcement of a report’s publication. Therefore, it should be classified as an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
소속부변경
Regulatory Filings
2026-04-30 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Regulatory Filings
2026-04-30 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 85% confidence The document is a Korean ‘공정공시’ notice detailing preliminary quarterly operating results (sales, operating profit, net profit) for Q1 2026. It lists only key headline figures and comparative periods without full financial statements or audit, matching an initial earnings announcement rather than a full interim report. Therefore, it fits the Earnings Release category. Q1 2026
2026-04-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a post-meeting announcement detailing the resolutions passed at the Annual General Meeting: approval of financial statements, dividend resolution, election of directors/auditors, record dates, vote counts and percentages, and names of newly appointed directors and auditors. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-03-26 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for i-SENS, Inc. (주식회사 아이센스) for the fiscal year ending December 31, 2025. It includes the independent auditor's report from Samjong KPMG, the full set of financial statements (Statement of Financial Position, Income Statement, Comprehensive Income Statement, Statement of Changes in Equity, and Cash Flow Statement), and detailed notes. Since it is a standalone audit report containing full financial statements and audit opinions, it is classified as an Audit Report (AR). FY 2025
2026-03-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.